Antapex Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.50 M
- Revenue Growth -81.28%
- Profit Growth 127.44%
- Ebitda 6937.36%
- Net Worth 41.81%
- Total Assets -50.19%
About Antapex Healthcare
Antapex Healthcare Private Limited (AHPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 November 2019 (Five years and two months 24 days old ). Its registered office is in Nashik, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹3.50 M.
Kapil Patil and Poonam Patil serve as directors at the Company.
Company Details
-
Location
Nashik, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24119MH2019PTC333185
-
Company No.
333185
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
18 Nov 2019
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Antapex Healthcare?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kapil Patil
|
Director | 18-Nov-2019 | Current |
|
Poonam Patil
|
Director | 07-May-2023 | Current |
Financial Performance of Antapex Healthcare.
Antapex Healthcare Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 81.28% decrease. The company also saw a substantial improvement in profitability, with a 127.44% increase in profit. The company's net worth Soared by an impressive increase of 41.81%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Antapex Healthcare?
In 2023, Antapex Healthcare had a promoter holding of 90.00% and a public holding of 10.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹3.50 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.35 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 May 2021 | Others | ₹3.50 M | Open |
How Many Employees Work at Antapex Healthcare?
Unlock and access historical data on people associated with Antapex Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Antapex Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Antapex Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
